Entera Bio ENTX
NASDAQ ENTX
$2.89 -0.02 (-0.69%)
At close: Oct 1, 2026 · 4:00 PM EDT

Entera Bio (ENTX) Invested Capital (2017 - 2026)

Updated

Entera Bio (ENTX) recorded Invested Capital of $7.55 million in Q2 2026, down 57.5% from $17.78 million a year earlier and down 32.9% from the prior quarter.

Analysis

Entera Bio (ENTX) Invested Capital (2017 - 2026) Analysis & Trends

For FY2025, Entera Bio reported Invested Capital of $13.49 million, up 67.0% from FY2024.

  • Across earlier years, Invested Capital came in at $8.08 million in FY2024.
  • The Q2 2026 figure is the lowest quarterly Invested Capital since Q4 2017.
  • Per Business Quant, the preceding three quarters came in at $11.25 million (Q1 2026), $13.49 million (Q4 2025) and $15.76 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 134.01 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 64.89 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 95.89 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 79.44 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.26 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 68.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 38.08 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 148.69 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Entera Bio 143.43 Mn 112.31 Mn - 7.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.55 Mn
Mar 31, 2026 11.25 Mn
Dec 31, 2025 13.49 Mn
Sep 30, 2025 15.76 Mn
Jun 30, 2025 17.78 Mn
Mar 31, 2025 19.89 Mn
Dec 31, 2024 8.08 Mn
Dec 31, 2017 -27.67 Mn
API Access

Entera Bio Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=ENTX&period=max&api_key=YOUR_API_KEY